Cargando…

Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya

INTRODUCTION: Wealth-based inequity in access to medicines is an impediment to achieving universal health coverage in many low-income and middle-income countries. We explored the relationship between household wealth and access to medicines for non-communicable diseases (NCDs) in Kenya. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockers, Peter C, Laing, Richard O, Wirtz, Veronika J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035514/
https://www.ncbi.nlm.nih.gov/pubmed/29989082
http://dx.doi.org/10.1136/bmjgh-2018-000828
_version_ 1783338070836248576
author Rockers, Peter C
Laing, Richard O
Wirtz, Veronika J
author_facet Rockers, Peter C
Laing, Richard O
Wirtz, Veronika J
author_sort Rockers, Peter C
collection PubMed
description INTRODUCTION: Wealth-based inequity in access to medicines is an impediment to achieving universal health coverage in many low-income and middle-income countries. We explored the relationship between household wealth and access to medicines for non-communicable diseases (NCDs) in Kenya. METHODS: We administered a cross-sectional survey to a sample of patients prescribed medicines for hypertension, diabetes or asthma. Data were collected on medicines available in the home, including the location and cost of purchase. Household asset information was used to construct an indicator of wealth. We analysed the relationship between household wealth and various aspects of access, including the probability of having NCD medicines at home and price paid. RESULTS: Among 639 patients interviewed, hypertension was the most prevalent NCD (69.6%), followed by diabetes (22.2%) and asthma (20.2%). There was a positive and statistically significant association between wealth and having medicines for patients with hypertension (p=0.020) and asthma (p=0.016), but not for diabetes (p=0.160). Poorer patients lived farther from their nearest health facility (p=0.050). There was no relationship between household wealth and the probability that the nearest public or non-profit health facility had key NCD medicines in stock, though less poor patients were significantly more likely to purchase medicines at better stocked private outlets. The relationship between wealth and median price paid for metformin by patients with diabetes was strongly u-shaped, with the middle quintile paying the lowest prices and the poorest and least poor paying higher prices. Patients with asthma in the poorest wealth quintile paid more for salbutamol than those in all other quintiles. CONCLUSION: The poorest in Kenya appear to face increased barriers to accessing NCD medicines as compared with the less poor. To achieve universal health coverage, the country will need to consider pro-poor policies for improving equity in access.
format Online
Article
Text
id pubmed-6035514
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-60355142018-07-09 Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya Rockers, Peter C Laing, Richard O Wirtz, Veronika J BMJ Glob Health Research INTRODUCTION: Wealth-based inequity in access to medicines is an impediment to achieving universal health coverage in many low-income and middle-income countries. We explored the relationship between household wealth and access to medicines for non-communicable diseases (NCDs) in Kenya. METHODS: We administered a cross-sectional survey to a sample of patients prescribed medicines for hypertension, diabetes or asthma. Data were collected on medicines available in the home, including the location and cost of purchase. Household asset information was used to construct an indicator of wealth. We analysed the relationship between household wealth and various aspects of access, including the probability of having NCD medicines at home and price paid. RESULTS: Among 639 patients interviewed, hypertension was the most prevalent NCD (69.6%), followed by diabetes (22.2%) and asthma (20.2%). There was a positive and statistically significant association between wealth and having medicines for patients with hypertension (p=0.020) and asthma (p=0.016), but not for diabetes (p=0.160). Poorer patients lived farther from their nearest health facility (p=0.050). There was no relationship between household wealth and the probability that the nearest public or non-profit health facility had key NCD medicines in stock, though less poor patients were significantly more likely to purchase medicines at better stocked private outlets. The relationship between wealth and median price paid for metformin by patients with diabetes was strongly u-shaped, with the middle quintile paying the lowest prices and the poorest and least poor paying higher prices. Patients with asthma in the poorest wealth quintile paid more for salbutamol than those in all other quintiles. CONCLUSION: The poorest in Kenya appear to face increased barriers to accessing NCD medicines as compared with the less poor. To achieve universal health coverage, the country will need to consider pro-poor policies for improving equity in access. BMJ Publishing Group 2018-06-22 /pmc/articles/PMC6035514/ /pubmed/29989082 http://dx.doi.org/10.1136/bmjgh-2018-000828 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research
Rockers, Peter C
Laing, Richard O
Wirtz, Veronika J
Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
title Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
title_full Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
title_fullStr Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
title_full_unstemmed Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
title_short Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
title_sort equity in access to non-communicable disease medicines: a cross-sectional study in kenya
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035514/
https://www.ncbi.nlm.nih.gov/pubmed/29989082
http://dx.doi.org/10.1136/bmjgh-2018-000828
work_keys_str_mv AT rockerspeterc equityinaccesstononcommunicablediseasemedicinesacrosssectionalstudyinkenya
AT laingrichardo equityinaccesstononcommunicablediseasemedicinesacrosssectionalstudyinkenya
AT wirtzveronikaj equityinaccesstononcommunicablediseasemedicinesacrosssectionalstudyinkenya